Personal Genome Diagnostics Appoints Brent Dial as Chief Financial Officer
Personal Genome Diagnostics appointed Brent Dial as Chief Financial Officer. He joins with 19 years of experience, most recently being Principal at Chordata Ventures, where he provided corporate finance advisory services and spent time as interim CFO for several portfolio companies.
Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. It is based in Baltimore, MD.